{"id":281790,"date":"2025-11-11T18:55:23","date_gmt":"2025-11-12T00:55:23","guid":{"rendered":"https:\/\/dallasinnovates.com\/?p=281790"},"modified":"2025-12-02T17:18:41","modified_gmt":"2025-12-02T23:18:41","slug":"dallas-curve-biosciences-raises-40m-for-its-whole-body-intelligence-disease-monitoring-platform","status":"publish","type":"post","link":"https:\/\/dallasinnovates.com\/dallas-curve-biosciences-raises-40m-for-its-whole-body-intelligence-disease-monitoring-platform\/","title":{"rendered":"Dallas’ Curve Biosciences Raises $40M for Its ‘Whole-Body Intelligence’ Disease Monitoring Platform"},"content":{"rendered":"

A Plano-born biotech founder has returned to North Texas to establish the headquarters for his company, Curve Biosciences, at Pegasus Park, the nationally recognized life science and biotech innovation hub in Dallas.<\/strong><\/p>\n

Curve announced it has raised $40 million in funding led by Luma Group with participation from First Spark Ventures, Techas Capital, Micah Spear, Civilization Ventures, LifeX Ventures, Incite, Mintaka VC, NZVC, and others.<\/p>\n

The company said the funding will advance the clinical validation and commercialization of its Whole-Body Intelligence platform, with a goal of “transforming” chronic disease monitoring.<\/p>\n

Curve\u2019s founder and CEO, Ritish Patnaik, left Texas to attend Columbia University in New York before moving to California to pursue his doctorate from Stanford University. He launched Curve several years ago, and had been operating it from an office in San Mateo, California. While the San Mateo remains open, Patnaik has now relocated the company’s headquarters to new Pegasus Park headquarters near his old home turf.<\/p>\n

\u201cChronic diseases are on the rise, and healthcare costs are skyrocketing as a result. We need to improve patient monitoring to realize the positive impacts of breakthroughs like GLP-1s,\u201d Patnaik said in a statement. \u201cTo raise the standard of chronic disease monitoring, we are now introducing the first Whole-Body Intelligence platform with AI models trained on our Whole-Body Atlas and fueled by our Whole-Body Blood Tests. We\u2019ve paired this platform with a successful executive team to realize our vision for proactive, personalized chronic care that minimizes suffering.\u201d<\/p>\n

Curve Biosciences, which calls itself the “Whole-Body Intelligence” company, has created what it calls “the first molecular blueprint of the human body” with its Whole-Body Atlas\u2014said to be the world\u2019s largest collection of manually curated tissue samples characterized by organ and disease state. By returning to “tissue-level biological truth,” the company says it’s creating simple, proactive Whole-Body Blood Tests that anticipate chronic disease, guide treatment, and align patients, insurers, pharma, and doctors.<\/p>\n

More on Curve founder and leadership<\/h3>\n

Born and raised in Plano, Patnaik attended Plano public schools and the University of North Texas before leaving in 2012 for Stanford. At the time of Patnaik’s graduation from Stanford, DFW lacked biotech infrastructure, presenting no viable path to build or fund a biotech company, the founder said.<\/p>\n

Flash forward to today. North Texas has established itself as a leading hub for biotech innovation, and the 26-acre Pegasus Park<\/a> campus is home to more than 885,000 square feet of office and lab space, including 37,000 square feet dedicated to BioLabs Pegasus Park<\/a>, designed for startups, and 135,000 more for Bridge Labs<\/a>, for those that graduate into the next phase of funding and growth.<\/p>\n

Curve\u2019s executive team includes, per the company:<\/p>\n